Theralase Technologies Inc.
TLTFF
$0.1378
-$0.0012-0.86%
OTC PK
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -78.34% | 15.39% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -78.34% | 15.39% | |||
| Cost of Revenue | -48.38% | -1.59% | |||
| Gross Profit | -95.05% | 27.72% | |||
| SG&A Expenses | 13.43% | 4.50% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 15.27% | 0.44% | |||
| Operating Income | -56.76% | 5.01% | |||
| Income Before Tax | -56.29% | 4.58% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -56.29% | 4.58% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -56.29% | 4.58% | |||
| EBIT | -56.76% | 5.01% | |||
| EBITDA | -60.17% | 5.17% | |||
| EPS Basic | -57.69% | 10.34% | |||
| Normalized Basic EPS | -62.50% | 11.11% | |||
| EPS Diluted | -57.69% | 10.34% | |||
| Normalized Diluted EPS | -62.50% | 11.11% | |||
| Average Basic Shares Outstanding | -3.35% | 9.28% | |||
| Average Diluted Shares Outstanding | -3.35% | 9.28% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||